The most common malignancies that develop in carriers of BAP1 germline mutations include
diffuse malignant mesothelioma, uveal and cutaneous melanoma, renal cell carcinoma, and …

Abstract AMD3100 (plerixafor), a CXCR4 antagonist, has opened a variety of avenues for
potential therapeutic approaches in different refractory diseases. The CXCL12/CXCR4 axis …

Malignant mesothelioma (MM) is an aggressive cancer primarily diagnosed on the basis of
histological criteria. The 2015 World Health Organization classification subdivides …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

Malignant pleural mesothelioma: recent developments : Current Opinion in Oncology Malignant
pleural mesothelioma: recent developments : Current Opinion in Oncology Log in or Register …

Introduction The 2015 WHO classification of tumors categorized malignant mesothelioma
into epithelioid, biphasic (BMM), and sarcomatoid (SMM) for prognostic relevance and …

Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Surgical intervention plays an important role in the diagnosis, staging, and treatment of
malignant pleural mesothelioma (MPM) and can be applied with curative or palliative intent …

Malignant mesothelioma (MM) is uncommon, but very aggressive tumor arising from the
mesothelial cells of pleura, pericardium, peritoneum, and tunica vaginalis. Despite …

Introduction Histologic subtypes of malignant pleural mesothelioma are a major prognostic
indicator and decision denominator for all therapeutic strategies. In an ambiguous case, a …